Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

admin
Pinned April 22, 2017

<> Embed

@  Email

Report

Uploaded by user
Man receives someone else’s reprogrammed stem cells
<> Embed @  Email Report

Man receives someone else’s reprogrammed stem cells

Jon Fingas, @jonfingas

April 02, 2017
 

Getty Images/iStockphoto

The concept of using stem cells for transplants just became a truly practical reality: a Japanese man with age-related macular degeneration has received the first transplant of stem cells from another human donor. Doctors repurposed the donor’s skin cells by turning them into induced pluripotent stem cells (that is, forced into a state where they can become many kinds of cells) that then became retinal cells. If all goes according to plan with the multi-step procedure, these fresh cells will halt the degeneration and preserve the patient’s remaining eyesight.

This isn’t the first time that human stem cells have been used. There was another macular degeneration treatment in 2014. However, the prior example revolved around taking samples from the patient’s own skin. That’s risky when they may be dealing with genetic flaws that could hinder the treatment. So long as the newest procedure proves a long-term success, it opens the door to plucking cells from healthier candidates.

And importantly, there are plans for this to become relatively commonplace. Researcher Shinya Yamanaka is developing a stem cell bank that would give recipients immediate treatment, instead of having to wait months to cultivate cells from a matching candidate. This would only potentially address about 30 to 50 percent of the Japanese population, but that could be enough to improve the quality of life for many people.

(46)

Pinned onto